Month: September 2024

Wealthy investors show a preference for Harris in a recent poll

Wealthy investors show a preference for Harris in a recent poll

More news - News 24 hours A recent poll points to a notable trend among wealthy investors, showing growing favoritism toward Harris over Trump in the political arena. This new data highlights a shift in the investment community, which could have significant implications for upcoming political campaigns. The survey, conducted among high-net-worth individuals, reveals that a majority now supports Harris, citing her policies and leadership style as key factors influencing their decision. This preference marks a change from previous trends in which Trump enjoyed significant support from this demographic. Experts suggest that Harris' proposed economic policies, which focus on sustainability…
Read More
Closing the antibiotic gap: access versus resistance in infection control

Closing the antibiotic gap: access versus resistance in infection control

Related media - Latest news The global fight against infectious diseases is undergoing a fundamental shift in perspective. For years, the dominant narrative around antimicrobial resistance (AMR) has focused on the overuse of antibiotics, painting a picture of a world grappling with increasingly ineffective drugs. While the dangers of overprescribing remain real, a growing chorus of experts argue that this focus overlooks a more fundamental issue: Millions of people don't have access to even the most basic antibiotics. At a recent United Nations meeting, health leaders highlighted this overlooked aspect of antimicrobial resistance. The inability of poor families to afford…
Read More
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of opioid overdose, study finds

Novo Nordisk’s diabetes drug Ozempic may reduce the risk of opioid overdose, study finds

More news - Latest news Recent research suggests that Ozempic, a diabetes treatment developed by Novo Nordisk, may play an unexpected role in reducing the risk of opioid overdose. The finding introduces a potentially game-changing approach in the ongoing battle against opioid-related deaths. The study, which delves into the effects of semaglutide (the active ingredient in Ozempic) on opioid receptors, suggests a promising link between use of the drug and decreased opioid cravings and potentially fatal overdoses. This insight is especially significant because it opens new avenues for the application of diabetes medications in addiction treatment therapies. Novo Nordisk’s Ozempic,…
Read More
Groundbreaking Carbon Sequestration Experiment Begins on Martha's Vineyard

Groundbreaking Carbon Sequestration Experiment Begins on Martha's Vineyard

More news - Latest news In a groundbreaking effort to combat climate change, scientists have introduced a new experiment off the coast of Martha's Vineyard, infusing ocean waters with a red dye. This marks the first phase of a series of trials to improve the ocean's ability to absorb carbon dioxide, according to the Woods Hole Oceanographic Institution. The project, conducted last year, serves as a precursor to larger interventions designed to increase the ocean's natural ability to sequester carbon. The initiative is based on the premise of enhancing biochemical processes that can lock away carbon dioxide for extended periods,…
Read More
Boeing workers are determined to extend the strike and say they are prepared to persist

Boeing workers are determined to extend the strike and say they are prepared to persist

More news - News 24 hours On the front lines of a major labor dispute, Boeing machinists lined up along the fence, showing they were ready for what could become a prolonged strike. “We are prepared to hold out as long as it takes,” said one striking worker, reflecting a strong resolve among the workers. As the strike at Boeing plants enters another week, resolve among machinists remains unwavering. The workers, who began striking nearly three weeks ago, are protesting terms they say fail to comprehensively address key concerns about wages, working conditions and benefits. The industrial action marks the…
Read More
Dr. John A. Clements, Pioneer of Lifesaving Neonatal Treatment, Dies at 101

Dr. John A. Clements, Pioneer of Lifesaving Neonatal Treatment, Dies at 101

Related media - Recent news Dr. John A. Clements, a preeminent figure in pulmonary science who deciphered critical lung function in the 1950s and later developed a revolutionary drug to treat lung failure in newborns, has died at his home in Tiburon, California. He was 101. His disappearance was confirmed by his daughter, Carol Clements. Dr. Clements' pioneering work began shortly after his graduation from Cornell University Medical College (now Weill Cornell Medical College) while serving as an Army physiologist. He was fascinated by the mechanics of human respiration, particularly how the tiny air sacs in the lungs manage to…
Read More